Establishment Labs Holdings Inc. announced the launch of Preservé™ in Brazil, marking the first country in its global rollout. Preservé is the second product within the company’s minimally invasive platform, building upon the technologies developed with Mia Femtech®.
Preservé is designed to enable less invasive breast surgery for day-to-day breast augmentation patients, accommodating size increases of up to four cups, hybrid augmentations, and mastopexy augmentations. This technology aims to preserve breast tissue, maintain structural anatomy, and improve safety profiles and recovery times.
Early launch results in Brazil showed orders at a price point more than double that of the most common SKUs, indicating strong market acceptance for its value proposition. The company plans additional global launches for Preservé throughout the year, expecting it to contribute to top-line growth and profitability.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.